Avalon GloboCare Provides Year-End Business Update of Selective Scientific and Clinical Programs Jan 4, 2022
Avalon GloboCare Jointly Files US and International Patent Application for Breakthrough S-Layer Coated Emulsome Technology (SLET) for Next-Generation Drug Delivery and Cellular Immunotherapy Oct 14, 2021
Avalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Co-develop Innovative In-Silico Technology, Enabling the Design and Synthesis of Novel Cell Membrane Receptor Targets for Cancer and Immune-Related Diseases Oct 7, 2021
Avalon GloboCare to Present at the Benzinga Healthcare Small Cap Conference on September 30th Sep 23, 2021
Avalon GloboCare Announces its Planned Acquisition Target, SenlangBio, has Initiated First-In-Human Clinical Trial in Recurrent Brain Cancer Jul 1, 2021
Avalon GloboCare CEO Provides Letter to Update Shareholders About Acquisition of SenlangBio Jun 28, 2021
Avalon GloboCare Announces Execution of Purchase Agreement for Acquisition of SenlangBio in All Stock Transaction Jun 14, 2021
Avalon GloboCare to Present at the Noble Capital Markets Investor Forum During the 16th Annual World Stem Cell Summit on June 17, 2021 Jun 11, 2021
